Charleston, SC -- (SBWIRE) -- 06/17/2013 -- The Team of advisers at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value.

Cannabis Science Inc(OTCMKTS:CBIS) closed yesterday at $0.0399, a -0.25% decrease. Around 2.58 million shares were traded, low from an-average trading volume of 2.75 million shares.

Cannabis Science Inc(OTCMKTS:CBIS) ended low -1.25% and complete the day at 0.0395. The total number of shares changed hands during the day was 1.94 million.

Cannabis Science, Inc., is a development-stage company. The Company is engaged in the creation of cannabis-based medicines, both with and without psychoactive properties, to treats disease and the symptoms of disease, as well as for general health ...

During the last one month it slipped with the percentage of -14.64. Its year to date performance remained adverse -17.20%. Cannabis Science Inc announced the appointment of clinical development expert, Dr. Dorothy Bray, Ph.D., as Chief Executive ...

Stamford, CT -- (SBWIRE) -- 06/11/2013 -- OTC Stock Picks is engaged in providing the most up to date and useful information on Best Penny Stocks poised to breakout.

Cannabis Science Inc (OTCMKTS:CBIS) remained a bear for the day as it reported the loss momentum of -1.50% and closed at $0.0394 after gaining total volume of 2.33 million shares.

About Cannabis Science, Inc.Cannabis Science, Inc. is conducting cannabinoid-based therapeutic research and development to address neglected pandemic oncological manifestations of pandemic infectious diseases in human health.

Cannabis Science Inc a development stage company, engages in the development, production, and commercialization of phytocannabinoid-based pharmaceutical products.

Cannabis Science, Inc. is researching on cannabis-based medicines and products. The company is also working on research and development in medical marijuana.